Dr. Chad V. Pecot, MD

Dr. Pecot practices at UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System.

Dr. Pecot's NPI, 1033266994, was assigned on January 4, 2007. Dr. Pecot graduated from University of Miami, Miller School of Medicine in 2006. Dr. Pecot's Texas license number on file is N2725.

Dr. Pecot's primary practice is UNC Hospitals, at 101 Manning Drive, Chapel Hill, NC 27514 in Orange County. The practice phone is (919) 966-4141.

Dr. Pecot's primary practice is UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System. The medical group on file is UNC Faculty Physicians. Dmand AI also links Dr. Pecot to 1 more therapy and rehab clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pecot practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Pecot's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Pecot is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Pecot's licenses on file in 3 states: Texas, North Carolina and Tennessee.

Dmand AI lists lung cancer among the conditions Dr. Pecot treats.

CMS data shows 123 Medicare services from Dr. Pecot across 2 procedure codes in 2024, for 26 Medicare patients. Medicare paid $6,963 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 26 Medicare patients who saw Dr. Pecot in 2024. 75% of them have cancer, and 69% have high blood pressure. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pecot's median patient age at 72, with 47% women.

In 2024, Dr. Pecot wrote 95 Medicare Part D claims for 18 patients. 68% of them were for generic drugs. CMS names the drug for 36 of them, across 3 drugs with 11 or more claims each, at $513,760 in total drug cost. In 2023, CMS named 60 claims across 4 drugs.

Dr. Pecot accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 63 papers to Dr. Pecot, published from 2010 to 2025. 2021 was the busiest year, with 7. The most frequent topics are Cell Line, Tumor, Lung Neoplasms and Gene Expression Regulation, Neoplastic. Dr. Pecot has published most often in Nat Commun. Dr. Pecot's most frequent co-authors are Anil K. Sood, MD, Gabriel Lopez-Berestein, MD and Behrouz Zand, MD.

CMS Open Payments shows 4 general payments to Dr. Pecot from 4 drug and device companies from 2016 to 2023. Education speaker fees make up the largest share, 63% of the total. Bristol-Myers Squibb Company paid the most, $250.

Dr. Pecot graduated from University of Miami, Miller School of Medicine in 2006.

Dr. Pecot is in network with 13 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.